Novo Nordisk Buys Ginkgo Autonomous Lab for New Waltham R&D Site
Ginkgo Bioworks announced on September 15, 2026 that it has been selected to build an autonomous lab powered by its Reconfigurable Automation Cart (RAC) architecture at Novo Nordisk's new U.S. research and development site in Waltham, Massachusetts. Novo Nordisk purchased the autonomous lab, and the agreement adds Ginkgo as a provider of the automation tools and software that power the company's internal laboratories for U.S. R&D. The agreement expands a relationship in which Novo Nordisk had…